---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-102144"
form_type: "8-K"
ticker: "WOOF"
cik: "0001826470"
company_name: "Petco Health & Wellness Company, Inc."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T15:01:21.956953+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Petco beats profitability goals in FY2025; reduces leverage to 3.0x; provides FY2026 outlook

## Summary
- Q4 net sales $1.5B (-2.4% YoY); comps -1.6%; Adjusted EBITDA $106.3M (+10.6%), above outlook.
- Full year net sales $6.0B (-2.5%); net income $9.1M vs loss of $101.8M; Adjusted EBITDA $408.2M (+21.3%).
- Leverage ratio improved from 4.2x to 3.0x; debt refinanced with $900M term loan and $600M bond, maturities extended to 2031.
- FY2026 guidance: net sales flat to +1.5% YoY; Adjusted EBITDA $415M-$430M; Q1 Adjusted EBITDA $92M-$94M.
- Free cash flow $187M, up 276.3%; inventory down 9.7%; net store closures ~15-20 for FY2026.

## SEC filing metadata
- accession: 0001193125-26-102144
- form_type: 8-K
- ticker: WOOF
- cik: 0001826470
- company_name: Petco Health & Wellness Company, Inc.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826470/000119312526102144/0001193125-26-102144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826470/000119312526102144/woof-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-102144
- JSON: https://secwatch.observer/filing/0001193125-26-102144.json
- Plain text: https://secwatch.observer/filing/0001193125-26-102144.txt

## Key facts
- Earnings Releases
  Petco Health & Wellness Company, Inc. reported quarter and year ended January 31, 2026 results: revenue $1.5 billion, net income Net loss of $2.6 million.
  - Period: quarter and year ended January 31, 2026
  - Revenue: $1.5 billion
  - Net income: Net loss of $2.6 million
  - Result: reported results
  source text: our strategic initiatives and assumes a return to positive comps in 2026.” Q4 2025 Overview For the fourth quarter of 2025 compared to the fourth quarter of 2024: • Net sales of $1.5 billion decreased 2.4%; comparable sales decreased 1.6%. • Gross profit decreased 1.4% to $580.8 million and gross margin increased 37 basis points to 38.3%. • Operating income increased
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826470/000119312526102144/0001193125-26-102144-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.